Stéphane Bancel | |
---|---|
Born |
Marseille, France | 20 July 1972
Education |
CentraleSupélec University of Minnesota Harvard Business School |
Occupation | Businessman |
Known for | CEO and 8% owner, Moderna |
Term | 2011– |
Spouse | Brenda Bancel |
Children | 2 |
Stéphane Bancel (born 20 July 1972) [1] is a French business executive. He is the chief executive officer (CEO) of the American pharmaceutical and biotechnology company Moderna, known for its COVID-19 vaccine. Before joining Moderna, Bancel was the CEO of French diagnostics company BioMérieux. Bancel is a partner at Flagship Pioneering, and has served on the boards of Indigo Agriculture, Boston's Museum of Science, and Qiagen. As of May 2023, his net worth was estimated at US$4.1 billion, owning about 8% of Moderna. [2]
Bancel was born in Marseille, France. His father and mother were an engineer and doctor, respectively. He enjoyed computers, math, and science during his childhood. [3]
Bancel studied engineering at CentraleSupélec (former École Centrale Paris) and biological engineering at the University of Minnesota, earning master's degrees at both institutions. [4] He went on to earn an MBA from Harvard Business School. [5]
Bancel was a sales director at Eli Lilly and Company, eventually becoming head of operations for Belgium. [5] In 2007, he became CEO of French diagnostics company BioMérieux, and was credited with improving the company's margins. [5]
In 2011, Bancel joined Moderna as the CEO. Stat reported that Bancel led a highly secretive culture with little outside review of its science or research. [5]
Bancel has two children. [6] In April 2020, with the Moderna share price rising on news of imminent phase 2 human trials for its potential COVID-19 vaccine, Bancel's stake of about 9% became worth over $1 billion. [4] He lives in Boston, Massachusetts. [2]
Stéphane Bancel | |
---|---|
Born |
Marseille, France | 20 July 1972
Education |
CentraleSupélec University of Minnesota Harvard Business School |
Occupation | Businessman |
Known for | CEO and 8% owner, Moderna |
Term | 2011– |
Spouse | Brenda Bancel |
Children | 2 |
Stéphane Bancel (born 20 July 1972) [1] is a French business executive. He is the chief executive officer (CEO) of the American pharmaceutical and biotechnology company Moderna, known for its COVID-19 vaccine. Before joining Moderna, Bancel was the CEO of French diagnostics company BioMérieux. Bancel is a partner at Flagship Pioneering, and has served on the boards of Indigo Agriculture, Boston's Museum of Science, and Qiagen. As of May 2023, his net worth was estimated at US$4.1 billion, owning about 8% of Moderna. [2]
Bancel was born in Marseille, France. His father and mother were an engineer and doctor, respectively. He enjoyed computers, math, and science during his childhood. [3]
Bancel studied engineering at CentraleSupélec (former École Centrale Paris) and biological engineering at the University of Minnesota, earning master's degrees at both institutions. [4] He went on to earn an MBA from Harvard Business School. [5]
Bancel was a sales director at Eli Lilly and Company, eventually becoming head of operations for Belgium. [5] In 2007, he became CEO of French diagnostics company BioMérieux, and was credited with improving the company's margins. [5]
In 2011, Bancel joined Moderna as the CEO. Stat reported that Bancel led a highly secretive culture with little outside review of its science or research. [5]
Bancel has two children. [6] In April 2020, with the Moderna share price rising on news of imminent phase 2 human trials for its potential COVID-19 vaccine, Bancel's stake of about 9% became worth over $1 billion. [4] He lives in Boston, Massachusetts. [2]